This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

PARIS/BOSTON (Reuters) - Biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially ...

CAMBRIDGE, Mass. & CARLSBAD, Calif.-Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), and Isis Pharmaceuticals Inc. (NASDAQ: ISIS), today announced that the Committee for Medicinal Products for ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 21, 2009 - Genzyme Corporation (Nasdaq: GENZ) announced today that it has submitted the final documentation to address all items in the FDA's complete response ...

CAMBRIDGE, Mass. – Genzyme Corp. (Nasdaq: GENZ) today announced that it has established a program to participate in efforts to discover and advance novel treatments for neglected diseases affecting ...

Genzyme Corp. and Integrated Genetics, which both launched themselves in 1981, became one in 1989, and since then Genzyme has used IG’s 51 New York Ave. location in Framingham to keep expanding.

* Agreement comes ahead of annual meeting set for June 16 * Genzyme to appoint Steven Burakoff, Eric Ende directors * Icahn to withdraw slate of four nominees to board * Genzyme's shares rise 0.1 ...

Ending nearly a year-long saga, Genzyme (NASDAQ:GENZ) agreed to a sweetened buyout from France’s Sanofi-Aventis (NYSE:SNY) on Wednesday that values the U.S. biotech giant at just north of $20 billion.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme Corporation (NASDAQ: GENZ) and Carl C. Icahn and certain of his affiliated private investment funds announced today an agreement to settle their proxy ...

About 18,000 gel-filled syringes sold by the Cambridge biotech Sanofi Genzyme to treat arthritis of the knee should not be used because that batch was linked to a surge in side effects, the company ...

French drugmaker Sanofi-Aventis SA has agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group's drugs, the companies said on ...